1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - TRACO 2017: Non-SCLC and HSP90 chaperone"}],["$","meta","1",{"name":"description","content":"Translational Research in Clinical Oncology (TRACO)\n

\nRecent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation sequencing, genomics and proteomics.\n

\nFor more information go to http://ccr.cancer.gov/training/trainee-resources/courses-workshops/traco"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - TRACO 2017: Non-SCLC and HSP90 chaperone"}],["$","meta","4",{"property":"og:description","content":"Translational Research in Clinical Oncology (TRACO)\n

\nRecent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation sequencing, genomics and proteomics.\n

\nFor more information go to http://ccr.cancer.gov/training/trainee-resources/courses-workshops/traco"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/b35218a8-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/90258446-54b3-459e-9508-e8567f8b0464.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - TRACO 2017: Non-SCLC and HSP90 chaperone"}],["$","meta","11",{"name":"twitter:description","content":"Translational Research in Clinical Oncology (TRACO)\n

\nRecent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation sequencing, genomics and proteomics.\n

\nFor more information go to http://ccr.cancer.gov/training/trainee-resources/courses-workshops/traco"}],"$L22","$L23","$L24"],"error":null,"digest":"$undefined"}